AnalystsArthur HeArthur He's Stock Forecasts
AnalystsArthur He
Sectors:
Industries:
Analyst Ranking
Top 4%
#157 out of 5077 analysts
Average Return
+44.43%
Win Rate
58%46 out of 80
Risk vs Reward
Poor
Good
Arthur He's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Nektar TherapeuticsNKTR | +391.37% | $12.23 | $60.10 | 2025-03-12 - 2025-10-24 | Buy |
Nektar TherapeuticsNKTR | +360.29% | $13.06 | $60.10 | 2025-02-24 - 2025-10-24 | Buy |
Poseida Therapeutics IncPSTX | +335.27% | $2.16 | $9.38 | 2024-04-21 - 2024-11-26 | Buy |
Nektar TherapeuticsNKTR | +316.81% | $14.42 | $60.10 | 2025-01-12 - 2025-10-24 | Buy |
Poseida Therapeutics IncPSTX | +294.12% | $2.38 | $9.38 | 2024-10-29 - 2024-11-26 | Buy |
Arthur He Analyst Color
Get additional color on Arthur He's coverage of popular stocks
Arthur He's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adagene IncADAG | 11 | Buy | $7.00 | +291.06% | Maintains | 2 months ago |
Lava Therapeutics NvLVTX | 11 | Hold | $1.24 | -22.98% | Maintains | 3 months ago |
Aurinia Pharmaceuticals IncAUPH | 1 | Buy | $17.00 | +42.98% | Assumes | 3 months ago |
Nektar TherapeuticsNKTR | 4 | Buy | $120.00 | +99.67% | Maintains | 4 months ago |
Solid Biosciences IncSLDB | 10 | Buy | $20.00 | +255.87% | Reiterates | 4 months ago |
Vera Therapeutics IncVERA | 2 | Buy | $85.00 | +190.90% | Maintains | 5 months ago |
Adaptimmune Therapeutics PLCADAP | 6 | Buy | $3.00 | +4,515.38% | Maintains | 7 months ago |
Prime Medicine IncPRME | 7 | Buy | $10.00 | +87.62% | Reiterates | 7 months ago |
Poseida Therapeutics IncPSTX | 17 | Hold | $9.00 | -5.26% | Downgrades | a year ago |
Hookipa Pharma IncHOOK | 6 | Buy | $60.00 | N/A | Maintains | a year ago |
Calliditas Therapeutics AbCALT | 4 | Hold | $39.00 | N/A | Downgrades | a year ago |
Bioatla IncBCAB | 6 | Buy | $7.00 | N/A | Reiterates | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.